Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Stride Inc. General Counsel Reports Share Withholding

Stride, Inc. (NYSE:LRN) Executive Vice President and General Counsel Greerson Greene McMullen filed a statement of changes in beneficial ownership on September 16, 2026, disclosing a share disposition on September 15, 2026.

Manish Choudhary | 16 September 2026

Kayne Anderson BDC Director Buys 400,000 Shares

A Form 4 filed on September 16, 2026 with the U.S. Securities and Exchange Commission reported that James L. Robo, a director of Kayne Anderson BDC, Inc. (NYSE:KBDC), acquired a total of 400,000 shares of common stock through two purchases on September 14 and …

Nitish Kishor | 16 September 2026

Corcept Therapeutics Director Sells Shares Under 10b5-1 Plan

Director James N. Wilson filed a Form 4 with the SEC on September 16, 2026, reporting the sale of 10,000 shares of Corcept Therapeutics Inc common stock on September 15, 2026, executed under a pre-established 10b5-1 trading plan.

Shwetambri Chauhan | 16 September 2026

Corcept Therapeutics Officer Sells Shares Under 10b5-1 Plan

Joseph Douglas Lyon, Chief Accounting and Technology Officer of Corcept Therapeutics Inc (NASDAQ:CORT), filed a Form 4 on September 16, 2026, reporting stock option exercises and open-market share sales that took place on September 14, 2026 pursuant to a previously adopted 10b5-1 plan.

Manish Choudhary | 16 September 2026

Intercontinental Exchange SVP Sells 1,600 Shares Under 10b5-1 Plan

Douglas Foley, Senior Vice President of HR and Administration at Intercontinental Exchange, Inc. (NYSE:ICE), filed a Form 4 on September 16, 2026, disclosing the sale of 1,600 shares of common stock on September 14, 2026.

Manish Choudhary | 16 September 2026

Veracyte Director Sells 5,000 Shares of Common Stock

A Form 4 filed with the SEC on September 16, 2026 discloses that Jens Holstein, a director of Veracyte, Inc. (NASDAQ:VCYT), sold 5,000 shares of common stock on September 14, 2026 under a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 16 September 2026

Doximity Chief Accounting Officer Reports Stock Option Exercise and Share Sale

Siddharth Sitaram, Chief Accounting Officer of Doximity, Inc. (NYSE:DOCS), filed a Form 4 on September 16, 2026, disclosing transactions dated September 15, 2026, involving the exercise of a stock option and a sell-to-cover sale of Class A Common Stock.

Manish Choudhary | 16 September 2026

JFrog Director Barry Zwarenstein Sells 1,250 Ordinary Shares

A Form 4 filed on September 16, 2026, reports that Barry Zwarenstein, a director of JFrog Ltd (NASDAQ:FROG), sold 1,250 ordinary shares on September 14, 2026, under a pre-established Rule 10b5-1 trading plan.

Nitish Kishor | 16 September 2026

Iridium Communications EVP Sells 5,769 Shares

A Form 4 filed on September 16, 2026 with the U.S. Securities and Exchange Commission reports that Timothy James Last, Executive Vice President of Sales and Marketing at Iridium Communications Inc. (NASDAQ:IRDM), disposed of 5,769 shares of common stock on September 15, 2026.

Vinay Lochav | 16 September 2026

Fastly CEO Sells 50,392 Shares Under 10b5-1 Plan

A Form 4 filed with the SEC on September 16, 2026, disclosed that Charles Lacey Compton III, CEO and Director of Fastly, Inc. (NASDAQ:FSLY), sold 50,392 shares of Class A Common Stock on September 14, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 16 September 2026
Support

Hi! How can we help you today?

Loading…